Minor Project Report 2

On

A Study on Sales Strategy and Competitive Analysis of Tata 1Mg

Submitted in Partial Fulfillment for the Award of the

Bachelors in Business Administration

Under the Guidance of: Submitted By:

Dr. Tanu Aggarwal Sarthak Bhowmick

Assistant Professor 13961101723

Maharaja Agrasen Institute of Management Studies

(A unit of Maharaja Agrasen Technical Education Society)
Affiliated to GGSIPU University; Recognized u/s 2(f) of UGC
Recognized by Bar Council of India; ISO 9001: 2015 Certified Institution
Maharaja Agrasen Chowk, Sector 22, Rohini, Delhi-110086
 Student Declaration

This is to certify that I, Sarthak Bhowmick have completed the Minor Project Report entitled
“A Study On Sales Strategy And Competitive Analysis Of Tata 1mg” under the guidance of Dr.
Tanu Aggarwal, Assistant Professor towards partial fulfilment of the requirement for the award
of the Degree of Bachelor of Business Administration at Maharaja Agrasen Institute of
Management Studies, Delhi. This is an original piece of work and I have not submitted it earlier
elsewhere.

Name of the Student: Sarthak Bhowmick

University Enrolment No: 13961101723
Program: BBA
Batch: 2023-2026
Date: 21.04.25

COUNTERSIGNED BY:

Name of Internal Faculty Guide: Dr Tanu Aggarwal

Designation: Assistant Professor
Date:

i
 Acknowledgement

Guidance, inspiration and motivation have always played a key role in the success of any
venture. I would like to pay my sincere regards to all those who guided me in my project work.
I would like to avail this opportunity to pay my sincere gratitude and regards to Prof. (Dr.) Rajni
Malhotra Dhingra, Director and Dr. Manoj Verma, HOD, Business Administration, Maharaja
Agrasen Institute of Management Studies for providing me such a wonderful opportunity to
widen the horizons of my knowledge. I would also like to express my heartfelt thanks to my
Project Guide Dr. Tanu Aggarwal, Assistant Professor for giving his support, guidance and
encouragement throughout the project work.
Last but not the least I would like to thank my parents, family and friends who have directly or
indirectly contributed in making this project a success.

Name of the Student: Sarthak Bhowmick

University Enrolment No: 13961101723
Program & Section: BBA, 4 G
Batch: 2023-26

ii
 Executive Summary

The Indian healthcare sector has undergone a significant digital transformation in recent years,
with e-pharmacy platforms emerging as key players in improving healthcare accessibility,
affordability, and convenience. Among these, Tata 1mg has established itself as a leading brand
by leveraging a robust digital sales strategy, a user-centric platform, and the trust associated
with the Tata Group.

This project report, titled “A Study On Sales Strategy And Competitive

Analysis Of Tata 1mg” explores how Tata 1mg drives customer acquisition and sustains its
market position through digital innovation, targeted sales tactics, and strategic partnerships. The
study delves into the company’s approach to direct-to-consumer (D2C) sales via its website and
mobile app, emphasizing its customer retention strategies such as referral programs,
subscription plans, and personalized engagement.

In addition to studying Tata 1mg in detail, the report presents a comparative analysis with its
key competitors in the Indian e-pharmacy space — NetMeds, PharmEasy, and Apollo 24/7.
This analysis helps highlight Tata 1mg’s unique positioning and competitive strengths in terms
of pricing strategies, service quality, delivery network, and customer trust.

The methodology of the report is primarily based on secondary research, including company
reports, market studies, and publicly available data. Tools such as SWOT analysis, sales funnel
mapping, and competitive benchmarking have been used to interpret the data.

The findings indicate that Tata 1mg’s sales success is driven by a combination of digital
convenience, diversified service offerings (such as diagnostics and e-consultations), and the
credibility of the Tata brand. However, the competitive landscape remains dynamic, requiring
continuous innovation and responsiveness to changing consumer needs.

This project concludes with observations and suggestions that could help Tata 1mg strengthen
its sales pipeline and further enhance customer acquisition and retention in the ever-evolving
Indian health-tech market.

iii
 Table of Contents

S No. Title Page No.

Student Declaration (i)
Acknowledgement (ii)
Executive Summary (iii)
1. Chapter 1: Introduction to the Company and Industry 1-13
1.1 History and Evolution of Tata 1mg
1.2 Overview of Tata 1mg’s Acquisitions
1.3 Industry Analysis – Indian Health-Tech/E-Pharmacy Industry
1.4 Key Competitors in the Industry
2. Chapter 2: Introduction to the Topic 14-16
2.1 Overview of Tata 1mg’s Sales Model
2.2 Hypothesis of the Study
2.3 Importance of Studying Sales Strategy and Customer Acquisition in E-Pharmacy
2.4 Scope and Limitations of the Study
3. Chapter 3: Review Of Literature 17-18
4. Chapter 4: Research Methodology 19-22
4.1 Research Type and Design
4.2 Data Sources and Approach
4.3 Tools of Analysis
5. Chapter 5: Data Analysis and Interpretation 23-44
5.1 SWOT Analysis of Tata 1mg
5.2 Customer Acquisition Funnel
5.3 Sales Funnel and Conversion Tactics
5.4 Comparative Study with NetMeds, PharmEasy, Apollo 24/7
5.5 Market Share & Revenue Breakdown
5.6 Pricing Strategies and Sales Offers
5.7 Role of Branding and Customer Trust
5.8 Competitors Analysis
5.9 Consumer Demographics and Behaviour Analysis
5.10 Impact of Tata Neu Ecosystem on Sales
5.11 Delivery Efficiency and Logistics
5.12 Mobile App Performance and User Ratings
5.13 Hypothesis Testing and Statistical Interpretation
6. Chapter 6: Findings and Observations 45-47
7. Chapter 7: Suggestions and Conclusions 48-51
8. References and Bibliography 52-54
9. Annexure 55-58
 Chapter 1 – Introduction To the Company

1.1 History and Evolution of Tata 1mg

1.1.1 Early Origins as HealthKartPlus (2012–2015)

Tata 1mg’s journey began in 2012 under a different name — HealthKartPlus. It was launched
by the parent company Bright Lifecare Pvt. Ltd., the same team behind HealthKart, a platform
focused on health supplements. HealthKartPlus was introduced as a free medicine information
portal that allowed users to compare the prices of branded and generic drugs, locate pharmacies,
and get access to authentic drug content.

The platform’s founding vision was to bring transparency and accessibility to healthcare
information, particularly medicines, which were often surrounded by misinformation, pricing
inconsistencies, and lack of awareness about cheaper generic alternatives.

1.1.2 Rebranding to 1mg and Expansion (2015–2020)

In 2015, HealthKartPlus was rebranded as 1mg Technologies Pvt.

Ltd. The name “1mg” symbolized the company’s ambition to
become a go-to solution for anything and everything related to
healthcare, starting with the most essential unit — 1 milligram.

During this phase, 1mg expanded its services beyond information. It

began offering:

• E-pharmacy services: Users could upload prescriptions and order medicines online.
• Diagnostic test bookings: By partnering with certified labs across cities.
• Teleconsultation with doctors: Making it easier for users to get medical advice from
their phones.
• Educational content: Informative blogs, medicine usage guides, and health-related
news.

By 2019, 1mg had served over 15 million users, built a delivery network across 1000+ cities,
and had become one of the most trusted names in the health-tech domain.

1.1.3 COVID-19 Pandemic as an Inflection Point (2020)

1
The outbreak of the COVID-19 pandemic marked a major inflection point in India’s health-
tech space. Lockdowns, limited access to physical pharmacies, and a growing demand for
remote diagnostics and doctor consultations led to a surge in digital healthcare adoption.

1mg responded quickly by:

• Launching at-home sample collection for COVID testing.

• Increasing teleconsultation capacity by onboarding more doctors.
• Expanding into chronic care management and subscription plans.
• Rolling out COVID-related awareness and myth-busting content on a mass scale.

Their agility and ability to scale rapidly during the crisis further solidified their position in the
market.

1.1.4 Acquisition by Tata Digital (2021)

In June 2021, Tata Digital Ltd., a subsidiary of Tata Sons, acquired a majority stake in 1mg.
With this acquisition, the platform was rebranded as Tata 1mg, aligning it with the Tata brand
known for trust, legacy, and nationwide reach.

This acquisition brought a significant strategic shift:

• Financial Muscle: Backed by Tata’s capital, the company could accelerate innovation,
logistics, and tech development.
• Brand Trust: The Tata name helped onboard more skeptical customers, especially in
Tier 2 and Tier 3 cities.
• Ecosystem Integration: Tata 1mg became a major health partner within Tata’s Neu
super app, offering rewards, bundled services, and cross-platform benefits.

1.1.5 Post-Acquisition Growth and Innovation (2022–Present)

Since becoming Tata 1mg, the platform has expanded aggressively across the following
verticals:

• Pharmacy: Rapid medicine delivery in metros, and improved access in smaller towns.
• Diagnostics: One of the largest at-home diagnostic test networks in India.
• e-Consultations: Increased availability of general physicians and specialists.

2
 • Subscription Programs: For chronic illness patients (like diabetes and hypertension),
offering discounts and regular checkups.
• Corporate Health Solutions: Partnering with organizations to offer employee health
packages.

The platform has now crossed over 40 million monthly active users, and is part of India’s
growing health-tech movement to deliver care that’s affordable, transparent, and digital-
first.

3
1.2 Overview of Tata 1mg’s Acquisition

1.2.1 Tata Group’s Digital Vision and Entry into Health-Tech

The Tata Group, one of India’s most diversified and trusted

conglomerates, has a legacy of adapting to evolving markets. In
the 2020s, it recognized the massive shift toward digital
consumption, especially in finance, retail, and healthcare. To
capitalize on this transformation, Tata Sons created Tata Digital
Ltd., a subsidiary specifically tasked with developing and
acquiring digital-first consumer businesses.

The Indian healthcare landscape, particularly after the COVID-19 outbreak, saw a surge in
online consultations, medicine deliveries, and digital diagnostic services. The health-tech sector
was booming, with rapid growth in user base, investments, and service innovation. Seeing this
trend, Tata Digital identified 1mg as an ideal entry point into the digital healthcare space.

1.2.2 The Acquisition Deal – Timeline and Structure

In June 2021, Tata Digital officially acquired a majority stake (approximately 55–60%) in 1mg
Technologies Pvt. Ltd. The financial details were not fully disclosed, but estimates placed the
deal between ₹700 to ₹900 crore.

This acquisition was part of a strategic trio of deals that Tata Digital executed in quick
succession:

• BigBasket (online groceries)

• 1mg (healthcare)

• CureFit (fitness and wellness)

These acquisitions were critical to the launch of Tata Neu, a “super app” combining multiple
services under one umbrella. As part of this strategy, 1mg was rebranded as Tata 1mg,
cementing its position as the Tata Group’s official health-tech offering.

1.2.3 Strategic Rationale Behind the Acquisition

The move wasn't just about entering a trending industry — it was deeply strategic. Here’s why:

4
 • Brand Trust & Customer Loyalty
The Tata brand is associated with trust, reliability, and quality. This helped 1mg
overcome skepticism that often surrounds online medicine platforms. The rebranding to
Tata 1mg significantly boosted customer confidence, especially in Tier 2 and Tier 3
markets.

• Operational Expansion and Infrastructure Boost

With Tata's backing, 1mg gained access to better supply chain management, logistics
partnerships, and deeper market penetration. It enabled faster delivery, broader
diagnostics coverage, and improved pharmacy stocking across India.

• Digital Synergy with Tata Neu

Tata 1mg became an essential service in the Tata Neu ecosystem. Customers could now
order medicines, book lab tests, or consult doctors — all while earning and redeeming
NeuCoins across Tata’s digital services like Croma, BigBasket, Air India, etc.

• Long-Term Growth Opportunity

India’s healthcare market is expected to reach over $372 billion by 2025, with digital
health services playing a vital role. By acquiring 1mg, Tata positioned itself to tap into
long-term value creation in chronic care, diagnostics, and digital wellness services.

1.2.4 Post-Acquisition Developments

Since the acquisition, Tata 1mg has scaled up operations significantly:

• Expanded its logistics and medicine delivery to cover 1000+ cities.

• Strengthened its in-house diagnostics labs and added more than 2500+ partner labs.

• Launched subscription-based care plans for lifestyle diseases.

• Introduced corporate health programs for companies and startups.

• Became the top-rated health app on both Android and iOS in India.

Additionally, Tata 1mg now caters to over 40 million users monthly and has become a vital part
of India’s growing digital health infrastructure.

5
1.3 Industry Analysis – Indian Health-Tech / E-Pharmacy Industry

1.3.1 Overview of the Indian Health-Tech Sector

India's healthcare system has long grappled with challenges related to accessibility,
affordability, and infrastructure, especially in rural and semi-urban areas. In recent years, the
emergence of digital infrastructure, increasing smartphone penetration, and access to affordable
internet have paved the way for a new sector: health-tech.

Health-tech refers to the integration of digital technology with healthcare services, enabling
solutions like online medicine delivery, teleconsultations, digital diagnostics, AI-driven
diagnosis, and remote patient monitoring.

As of 2023, the Indian health-tech market is valued at approximately $2.9 billion and is
expected to grow at a CAGR of 35–40%, reaching over $50 billion by 2030. The key drivers
of this growth include rising consumer awareness, an increase in chronic diseases, a greater
push for wellness and preventive care, and supportive government initiatives like the National
Digital Health Mission.

1.3.2 E-Pharmacy: A Transformative Subsector

The e-pharmacy vertical has revolutionized medicine access in India. Platforms such as Tata
1mg, NetMeds, PharmEasy, and Apollo 24|7 have enabled users to order medicines from their
homes with just a few clicks.

Key services offered by e-pharmacies include:

• Prescription and OTC medicine delivery

• Access to generic alternatives

• Monthly refill subscriptions

• Health blogs and product information

• Teleconsultations with verified doctors

• Discounted diagnostic test bookings

Market data suggests that India's e-pharmacy segment was worth around ₹25,000 crore in 2023
and is expected to grow rapidly, especially in Tier 2 and Tier 3 cities where physical access to
quality healthcare is limited.

6
1.3.3 Consumer Behavior and Emerging Trends
post-COVID-19, there has been a substantial behavioral shift among Indian consumers
regarding health and wellness.

• People are now more proactive about preventive healthcare.

• There is increased demand for at-home services such as diagnostics and consultations.

• Users are open to paying for convenience and faster delivery.

• Telemedicine is gaining wide acceptance even among senior citizens.

Moreover, digital health platforms are seeing high engagement through value-added services
such as:

• Subscription plans for chronic illness management

• Regular health tips and personalized care

• Wellness kits and immunity boosters

• Integration with fitness trackers and wearable tech

1.3.4 Regulatory Landscape and Challenges

The Indian e-pharmacy space operates under a partially defined regulatory framework
governed by the Drugs and Cosmetics Act, 1940, and guidelines from the Central Drugs
Standard Control Organisation (CDSCO). However, there are no dedicated laws for online
pharmacies yet, making the environment a bit unpredictable.

Some of the challenges faced by players in the industry include:

• Regulatory uncertainty around e-pharmacy licenses

• Legal challenges from offline pharmacy associations

• Logistics hurdles in remote locations

• Ensuring data privacy and secure prescriptions

• Counterfeit drugs and verification issues

Despite these issues, the government is increasingly leaning towards digital healthcare solutions
as part of its long-term healthcare vision.

7
1.3.5 Future Outlook
The Indian health-tech sector is poised for massive expansion. Key future trends include:

• Integration of AI and machine learning in diagnosis and personalized care

• Wider use of electronic health records and digital health IDs

• Growth in vernacular and regional healthcare apps

• Public-private partnerships in rural healthcare delivery

• Entry of global investors and healthcare players

With a growing digital-first population and increasing demand for affordable healthcare,
platforms like Tata 1mg are well-positioned to lead the next phase of innovation and service
delivery in this industry.

8
1.4 Key Competitors in the Industry

1.4.1 Overview of Competition in the E-Pharmacy Space

India’s digital health ecosystem is becoming increasingly competitive, with multiple players
fighting for market share in the e-pharmacy, telemedicine, and diagnostic spaces. While Tata
1mg holds a strong and growing position due to its brand backing and service quality, it faces
stiff competition from both well-funded startups and legacy healthcare giants.

The major competitors in this sector include:

• PharmEasy

• NetMeds (acquired by Reliance)

• Apollo 24|7

• MediBuddy

• Flipkart Health+

Each of these players has a unique strategy, whether it's integration with hospitals, strong supply
chains, or digital-first innovations.

1.4.2 Competitor Profiles and Positioning

PharmEasy

• Founded in 2015, PharmEasy is one of the largest players

in the Indian e-pharmacy space.

• It offers a wide range of services, including online medicine delivery, lab tests, and
doctor consultations.

• PharmEasy merged with diagnostics company Thyrocare, giving it a strong foothold in

diagnostics.

• It heavily relies on discount-based customer acquisition.

9
NetMeds (Reliance Health)

• NetMeds was acquired by Reliance Retail Ventures in 2020.

• Backed by the power of Reliance's digital and retail networks,

NetMeds has rapidly expanded its reach, especially in Tier 2
and rural markets.

• Integrated into Reliance's Jio ecosystem, offering bundled services with telecom and
digital platforms.

• Focuses on leveraging logistics and reach over aggressive pricing.

Apollo 24|7

• A digital wing of Apollo Hospitals, one of India’s most trusted

healthcare brands.

• Offers end-to-end digital healthcare services: medicines,

consultations, diagnostics, and health records.

• Strong integration with Apollo’s physical hospital network.

• Attracts customers with a trust-based clinical model rather than discounts.

MediBuddy

• Focuses on employee wellness and B2B healthcare services.

• Partners with corporates to offer teleconsultation, health checkups,

insurance claims, and mental health services.

• Less focused on e-pharmacy retail but significant in digital consultations and wellness.

Flipkart Health+

• Flipkart, a Walmart-owned e-commerce giant, launched its

healthcare venture by acquiring SastaSundar Healthbuddy.

• Uses Flipkart’s tech and customer base to expand e-pharmacy

and diagnostic offerings.

• Integrates medicine shopping with other Flipkart offerings, backed by a strong logistics
framework.

• Still in an early growth phase but with massive scaling potential.

10
1.4.3 Comparative Analysis of Key Players

Here’s a plain-text comparison of the top competitors across key metrics:

Tata 1mg

• Backed by: Tata Group

• Strengths: Brand trust, user-friendly interface, strong diagnostics presence

• Weaknesses: Slightly premium pricing compared to discount-driven competitors

• Differentiator: Integration with Tata Neu super app

PharmEasy

• Backed by: Multiple VC investors

• Strengths: Aggressive marketing, widest pharmacy delivery coverage

• Weaknesses: Profitability concerns due to high discounting

• Differentiator: Thyrocare integration for diagnostics

NetMeds

• Backed by: Reliance Retail

11
 • Strengths: Massive funding, logistics scale, rural reach

• Weaknesses: Less personalized user experience

• Differentiator: Reliance ecosystem support

Apollo 24|7

• Backed by: Apollo Hospitals

• Strengths: Healthcare credibility, hospital integration

• Weaknesses: Less tech-savvy user base

• Differentiator: Trust in clinical expertise

MediBuddy

• Backed by: Investors like Lightrock

• Strengths: Strong B2B corporate tie-ups

• Weaknesses: Lower visibility in retail e-pharmacy

• Differentiator: Employee wellness and corporate packages

Flipkart Health+

• Backed by: Flipkart (Walmart)

• Strengths: Tech, logistics, existing e-commerce base

• Weaknesses: New player, still building trust in health

• Differentiator: E-commerce integration with health

12
1.4.4 Competitive Advantage of Tata 1mg

What sets Tata 1mg apart in this crowded space?

• Brand Equity: The Tata name instills unmatched trust, especially in a sector where
credibility is crucial.

• Balanced Offering: Unlike some players that over-focus on one vertical, Tata 1mg
offers a balanced mix of e-pharmacy, diagnostics, consultations, and health content.

• Subscription Ecosystem: Tata 1mg’s care plans and integration with Tata Neu add
long-term value to customers.

• Superior User Interface: The platform is consistently rated highly for user experience,
search functionality, and transparency in pricing and substitutes.

• Customer Support and After-Sales: Known for prompt issue resolution, refund
policies, and verified medicines.

13
 Chapter 2 – Introduction to the Topic

2.1 Understanding the Rise of Tata 1mg

2.1.1 From Startup to Super App Integration

Tata 1mg, originally launched as 1mg in 2015, started as a platform to educate users about
generic medicines. Over time, it expanded into a comprehensive digital healthcare platform
offering services such as e-pharmacy, lab test bookings, doctor consultations, and health-related
content.

In 2021, the company was acquired by Tata Digital, giving it a significant edge in both funding
and brand credibility. Post-acquisition, Tata 1mg was integrated into the Tata Neu Super App,
which brought it under a broader digital commerce ecosystem alongside brands like Croma,
BigBasket, and Air India. This integration allowed for cross-platform synergy, creating more
touchpoints with consumers and increasing visibility across various verticals of everyday
utility.

2.1.2 Product and Service Ecosystem

Tata 1mg's offerings span multiple categories, giving it a unique position as a full-service
health-tech platform:

• Online medicine delivery (prescription and over-the-counter)

• Diagnostics and lab test booking with home sample collection

• Online doctor consultations with specialists and general physicians

• Verified and comprehensive medicine information and health content

• Health and wellness subscriptions

• Corporate wellness programs and chronic care packages

This wide range of offerings makes Tata 1mg more than just a pharmacy app — it positions
itself as a comprehensive health partner for urban and semi-urban India.

14
2.2 Significance of the Study

2.2.1 Relevance to Sales Management

Tata 1mg provides an excellent case study to understand digital-first sales techniques. The study
ties into core sales management concepts such as customer segmentation, funnel management,
lead generation, customer lifecycle value, and CRM integration.

2.2.2 Academic Value

This study bridges the gap between theoretical frameworks and real-world application. It
showcases how principles of sales strategy, consumer psychology, and marketing
communication are being implemented in a fast-evolving industry.

2.2.3 Practical Business Relevance

E-pharmacy is one of India’s fastest-growing sectors. By analyzing a leading player’s growth

and marketing strategy, the study offers practical insights for marketers, entrepreneurs, and
business strategists aiming to operate in digital healthcare.

2.2.4 Consumer Behavior Insight

Understanding how Indian consumers interact with platforms like Tata 1mg helps decode
broader health consumption patterns. Factors like brand trust, pricing sensitivity, user interface
design, and delivery timelines all impact purchase behavior in this domain.

2.4 Scope of the Study

• The study is restricted to Tata 1mg’s operations in India.

• The focus is on its sales and marketing strategies, especially post-acquisition by Tata
Digital.

• A comparative view of competitors such as PharmEasy, NetMeds, and Apollo 24|7 is

included.

• The research covers both online and offline aspects of digital healthcare sales.

• The timeline primarily spans from 2021 to 2024.

15
2.4.1 Limitations of the Study

• Primary data from internal sales reports and financials is unavailable.

• Market dynamics may change rapidly with new entrants and mergers.

• Consumer behavior insights are based on secondary data and publicly available reports.

• The study does not delve into clinical efficacy or backend technology infrastructure.

16
 Chapter 3 – Review Of Literature

The study highlights the growing importance of trust, digital integration, and competitive
positioning for platforms like Tata 1mg. Prior research also examines how pricing strategies,
customer loyalty programs, and tech-based engagement tools influence consumer decision-
making in the healthcare e-commerce space.

Brown and Dacin (1997) emphasized that corporate associations, including brand image and
social responsibility, strongly influence consumer evaluations of products and services. This
foundational theory underlines how Tata 1mg, by being associated with the trusted Tata brand,
gains a significant edge in consumer trust and brand loyalty in the healthcare e-commerce
domain.

Kotler and Keller (2016) argued that digital marketing, personalization, and direct consumer
engagement are key levers in modern sales management. This aligns well with the e-pharmacy
business model, where platforms like Tata 1mg use app-based engagement, push notifications,
and CRM systems to enhance consumer interaction and repeat sales.

Verma and Sinha (2020) found that customer satisfaction in the e-pharma industry is largely
determined by timely delivery, quality assurance, and after-sales support. These factors
resonate with Tata 1mg’s focus on logistical efficiency and their provision of certified
medicines, lab diagnostics, and expert consultation under one platform.

Saha and Bhattacharya (2021) analyzed the growth of digital pharmacies in India and
highlighted how trust and transparent pricing influence customer acquisition and retention. Tata
1mg's pricing strategies, verified prescriptions, and genuine product sourcing seem to be built
around these very insights.

Garg, Bhalla, and Bhattacharya (2019) studied consumer behavior in online pharmacy adoption
and found that younger demographics (25–34 years) dominate digital pharmacy usage. Tata
1mg’s internal user analytics also reflect this trend, showing that this age group contributes the
highest share of platform users.

Bharti and Singh (2022) emphasized the role of health tech integration and smart analytics in
boosting operational efficiency and personalizing health services. Tata 1mg’s partnership with

17
Tata Neu, and its data-driven ecosystem, reinforces this as a competitive advantage in market
positioning and customer service.

Chauhan and Kaushik (2023) explored the influence of cross-platform synergies in super apps
and concluded that integrated service ecosystems lead to higher customer lifetime value (CLV).
Tata 1mg’s integration within the Tata Neu app—offering NeuCoins, loyalty benefits, and
consolidated user profiles—enhances brand stickiness.

Dey and Kumar (2020) noted that consumer trust in healthcare e-commerce is significantly
impacted by visible certifications, prescription compliance, and third-party lab approvals. Tata
1mg leverages these elements by showcasing certifications and offering NABL-accredited lab
tests, enhancing its credibility.

Rao and Reddy (2021) discussed the pricing wars among Indian e-pharmacies, stating that
discount-driven acquisition strategies are useful in short-term market capture but not always
sustainable. Tata 1mg attempts to strike a balance through moderate discounting alongside
membership-based benefits like the "1mg Care Plan."

Dasgupta and Mehta (2023) studied mobile health (mHealth) app adoption and reported that
app UI/UX, speed, and personalized recommendations play vital roles in maintaining high user
engagement. Tata 1mg’s high mobile usage percentage and increasing female user base reflect
successful execution in this domain.

Sharma and Kapoor (2018) explored the effect of word-of-mouth (WOM) and online reviews
on purchase intent in healthcare apps. Their research supports the strategy of encouraging user
feedback and showcasing high app store ratings, something Tata 1mg does effectively with over
4.3 stars on both Android and iOS.

Patel and Nambiar (2021) concluded that consumer loyalty in the e-health sector hinges not just
on pricing but on perceived brand reliability, post-sales engagement, and convenience. Tata
1mg’s round-the-clock service, transparent return policies, and robust customer support
indicate adherence to these principles.

18
 Chapter 4 - Research Methodology

4.1 Research Type and Design

Research methodology is a critical component of any analytical study. It defines the path
followed for collecting, analyzing, and interpreting data to arrive at valid conclusions. For this
project on Tata 1mg’s sales and marketing strategies, a qualitative and descriptive approach
has been adopted, with some elements of comparative and analytical research.

4.1.1 Research Type

This research is a qualitative study that focuses on observing patterns, behaviors, and strategies
implemented by Tata 1mg in the digital healthcare and e-pharmacy industry. The aim is to
understand how Tata 1mg positions itself in the market, engages customers, and competes with
other players.

In addition, the study includes comparative analysis, as it compares Tata 1mg's performance
and strategies with competitors such as PharmEasy, NetMeds, and Apollo 24|7.

4.1.2 Research Design

The research design for this study is descriptive and exploratory in nature:

• Descriptive design helps outline Tata 1mg’s business model, services, marketing
strategies, and brand-building efforts.

• Exploratory design aids in identifying new dimensions in India’s e-health space and
the company’s potential for future growth.

This design is suitable for understanding broad trends, analyzing current practices, and
identifying areas for improvement and innovation.

4.1.3 Research Objectives

• To analyze Tata 1mg’s sales and marketing strategies.

• To understand the brand positioning after the acquirement of Tata

• To analyse the competitors of Tata 1mg’s in the Indian health-tech industry.

• To interpret how the marketing strategies affect the consumers.

19
4.2 Data Sources and Approach

4.2.1 Data Sources

This study primarily utilizes secondary data, due to the absence of primary field research (like
surveys or interviews). The data is collected from various reliable and publicly available
sources:

• Company Websites: Tata 1mg and its competitors (PharmEasy, NetMeds, Apollo 24|7)

• Tata Group Publications and Newsletters

• Business News Portals: Economic Times, Business Standard, Mint, LiveMint, etc.

• Industry Reports: RedSeer, KPMG, EY Healthcare Reports, Invest India

• Mobile Apps and User Reviews: App Store and Play Store ratings, consumer feedback

• Social Media and Digital Ads: Observing Tata 1mg’s promotional content on
Instagram, YouTube, and Facebook

• Academic Journals and Case Studies on digital healthcare

While secondary data limits the ability to obtain deep internal insights, it remains a valid and
effective way to analyze large-scale industry patterns and strategic decisions.

4.2.2 Data Collection Approach

The approach followed is thematic and comparative:

• Thematic Analysis: Categorizing data into relevant themes such as sales funnel,
branding, customer acquisition, etc.

• Comparative Analysis: Evaluating Tata 1mg’s approach against competitors in terms

of pricing, branding, innovation, customer retention, and product diversity.

4.2.3 Research Framework

A strategic marketing framework is used to understand:

• The brand’s positioning

• Customer engagement tactics

• Use of technology in sales strategy

20
 • The impact of corporate ownership (Tata Group)

• External industry factors such as regulations and competition

4.3 Tools of Analysis

4.3.1 SWOT Analysis

A detailed SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis is used to

understand Tata 1mg’s internal capabilities and external market environment. This tool offers
a balanced view of the company’s current performance and future outlook.

4.3.2 Competitor Benchmarking

Competitor benchmarking is used to measure Tata 1mg’s performance and offerings relative to
competitors like:

• PharmEasy – Market leader with aggressive pricing and acquisitions

• NetMeds – Backed by Reliance Retail, strong logistics

• Apollo 24|7 – Offline-online integration, hospital support This comparison provides

clarity on what Tata 1mg does differently and what its competitive edge is.

4.3.3 Market Share Analysis

A graphical representation (pie chart) of market share is included in Chapter 4 to visualize

where Tata 1mg stands within the Indian e-pharmacy landscape. This includes publicly
available estimates from research firms and business media sources.

4.3.4 Revenue Breakdown

Where available, the revenue contributions from Tata 1mg’s service categories (e.g.,
diagnostics, pharmacy, consultations) are analyzed to show which verticals are driving growth.

4.3.5 Digital Marketing Analysis

Using digital ad content, platform messaging, and social media presence, the analysis evaluates
how Tata 1mg communicates with its target market. Observations are made regarding:

• Frequency and nature of promotions

21
 • SEO and blog strategy

• App notifications and personalized offers

• Content strategy on YouTube and Instagram

4.3.6 Consumer Review Analysis

Customer sentiment and feedback are gathered through:

• App reviews (Google Play, Apple Store)

• Testimonials and ratings on lab test services

• Social media comments and responses This helps gauge customer satisfaction, service
gaps, and potential improvements.

22
 Chapter 5 – Data Analysis and Interpretation

5.1 SWOT Analysis of Tata 1mg

The SWOT analysis provides a structured assessment of Tata 1mg’s strategic position in the
Indian digital healthcare market.

Strengths (Internal- Weaknesses

Positive) (Internal- Negative)

Opportunities Threats (External –

(External – Positive) Negative)

Strengths

• Backing of Tata Group – a symbol of trust and legacy.

• Wide service range: pharmacy, diagnostics, teleconsultation, health content.
• User-friendly app and website with high engagement rates.
• Nationwide presence with strong logistics and fulfillment capabilities.

Weaknesses

• High dependency on digital platforms (app/website)—limits users unfamiliar with tech.

• Less physical presence compared to Apollo.
• Limited differentiation in pricing compared to aggressive discounting by competitors.

Opportunities

• Expansion into tier-2 and tier-3 cities with localized strategies.

• Rise in healthcare awareness post-COVID.
23
 • Growing demand for chronic care, mental health, and wellness services.
• Integration into Tata Neu offers strong cross-platform visibility.

Threats

• Regulatory uncertainties in the e-pharmacy space.

• Price wars eroding profit margins.
• Increased competition from Reliance (NetMeds), Apollo, and PharmEasy.

5.2 Customer Acquisition Funnel

Tata 1mg’s customer acquisition follows a digital-first approach using advertising, SEO, app
installs, and Tata ecosystem integration.

Stage Description Funnel Drop-off (%)

Awareness Online ads, influencer marketing, Tata Neu 100%

Interest Visiting website, browsing categories 70%

Consideration Reading reviews, comparing prices 50%

App Installation Downloading the app or registering 40%

First Purchase Buying medicine, booking lab tests 25%

Repeat Usage Subscription, offers, auto-reminders 15%

24
 Customer Acquisiton Funnel

Awareness 100%

Interest 70%

Consideration 50%

App Installation 40%

First Purchase 25%

5.2.1 Interpretation of Data

Interpretation:

The funnel chart illustrates the progressive narrowing of Tata 1mg’s customer base across
different acquisition stages. Starting with full awareness at 100%, there is a significant drop-off
at each level, especially between Interest (70%) and First Purchase (25%). This suggests that
while Tata 1mg effectively generates visibility through digital ads, influencer marketing, and
Tata Neu integration, a major challenge lies in converting interest into actual transactions. The
retention further drops to 15% at the Repeat Usage stage, indicating the need for stronger
engagement strategies like personalized offers, loyalty programs, and improved app experience
to drive continued usage.

25
5.3 Sales Funnel and Conversion Tactics

Sales funnels are optimized through tech-driven engagement and tactical offers.

Funnel Stage Conversion Technique Tools Used

First Visit Welcome discount offers (15–20% Push notifications, banners
off)
Abandoned Cart Reminder emails, app notifications Email marketing, retargeting
ads
Purchase Fast checkout, multiple payment UPI, Cards, Wallets
Completion options
Post-Purchase Loyalty points via Tata Neu, review Tata Neu integration, referral
requests codes

Abondoned Purchase Post

First Visit
Cart Completion Purchase

5.3.1 Interpretation of Data

The arrow chart outlines Tata 1mg’s targeted conversion strategies at each stage of the sales
funnel. Initial engagement is driven by attractive welcome discounts and visual triggers like
banners and push notifications. To recover potential drop-offs, especially at the abandoned cart
stage, the brand employs retargeting ads and reminder emails. For smooth purchase completion,
seamless checkout options across UPI, cards, and wallets are made available. Post-purchase
efforts focus on retention and advocacy, with loyalty rewards through Tata Neu and
encouragement for referrals and reviews. This holistic approach reflects a smart blend of
technology and incentives to drive higher conversion rates throughout the funnel.

26
5.4 Comparative Study with NetMeds, PharmEasy, Apollo 24/7

Feature/Parameter Tata 1mg NetMeds PharmEasy Apollo 24/7

Parent Company Tata Digital Reliance API Holdings Apollo
Retail Hospitals

Mobile App UX Excellent Moderate Good Good

Diagnostics Strong, Limited Average Strong
growing

Offline Integration Low None Low High

Loyalty Program Tata Neu Coins Reliance One PharmEasy Health Credits
Cash

Pricing Strategy Competitive Aggressive Very Premium

Aggressive

Trust Factor High Moderate Moderate High

Comparative Study
Tata 1mg NetMeds PharmEasy Apollo 24/7
App UX
5

2
Brand Trust Diagnostics Services
1

Pricing Strategy Offline Integration

5.4.1 Interpretation of Data

The comparative analysis visually highlights the positioning of Tata 1mg, NetMeds,
PharmEasy, and Apollo 24/7 across critical service parameters. Tata 1mg leads in App UX and

27
Brand Trust, showcasing its user-friendly interface and credibility under the Tata brand. Apollo
24/7 stands out in Offline Integration and Diagnostics, benefiting from its hospital network.
PharmEasy aggressively competes on Pricing but shows only moderate performance in other
categories. NetMeds, while backed by Reliance, lags in diagnostics and offline integration.
Overall, Tata 1mg maintains a balanced and strong position in digital presence, customer trust,
and loyalty programs, as reflected in the radar chart.

5.5 Market Share & Revenue Breakdown

Market Share Estimates (2024)

Company Market Share (%)

PharmEasy 32%
Tata 1mg 22%
NetMeds 18%
Apollo 24/7 15%
Others 13%

Market Share (%)

13%
PharmEasy
32% Tata 1mg
15% NetMeds
Apollo 24/7
Others
18%
22%

28
The pie chart illustrates the estimated e-pharmacy market share distribution in India for 2024.
PharmEasy dominates with a significant 32% share, leveraging aggressive pricing and
widespread brand recall. Tata 1mg follows with 22%, reflecting steady growth backed by Tata
Group’s digital strategy and trust factor. NetMeds and Apollo 24/7 hold 18% and 15%
respectively, with Apollo benefiting from its strong offline integration. The remaining 13% is
split among smaller or niche players. The data highlights a competitive landscape, with Tata
1mg emerging as a strong contender aiming to close the gap with the market leader.

5.5.1 Tata 1mg Revenue Contribution by Segment

Segment Estimated Contribution (%)

Pharmacy (Medicines) 50%

Diagnostics & Lab Services 25%

Doctor Consultations 10%

Health & Wellness Products 10%

Subscriptions & Memberships 5%

Estimated Contribution (%)

5%
10%

10%
Pharmacy (Medicines)

50% Diagnostics & Lab Services

Doctor Consultations
25% Health & Wellness Products

5.5.2 Interpretation of Data

29
The donut chart shows that Pharmacy sales make up the bulk of Tata 1mg’s revenue (50%),
followed by Diagnostics & Lab Services (25%). Doctor Consultations and Health & Wellness
products contribute equally (10% each), while Subscriptions & Memberships add the remaining
5%. This indicates a heavy reliance on medicine sales, with diagnostics as a strong secondary
revenue stream.

5.6 Pricing Strategies and Sales Offers

Tata 1mg focuses on offering value over deep discounts, unlike PharmEasy. Key tactics:

Offer Type Frequency Effectiveness (Est. Conversion %)

First Order Discount High 35%

Diagnostic Combo Offers Medium 22%

Seasonal Campaigns (e.g., Monsoon) Medium 15%

Tata Neu Cashback High 40%

Effectiveness of the Strategy Offers

Tata Neu Cashback

Seasonal Campaigns

Diagnostic Combo Offers

First Order Discount

0 0.5 1 1.5 2 2.5 3 3.5

Conversion % Frequency (Score)

30
5.6.1 Interpretation of Data

The bar graph illustrates that Tata Neu Cashback and First Order Discounts are the most
effective offers in driving conversions (40% and 35%, respectively), both used frequently.
Diagnostic Combo Offers and Seasonal Campaigns are moderately used with lower conversion
rates (22% and 15%), suggesting room to optimize these for better impact.

Tata 1mg’s biggest advantage lies in brand trust from its Tata association. Marketing and
branding strategies include:

• Featuring “A Tata Enterprise” prominently in communications.

• Use of real customer testimonials.
• Content-driven trust (blogs, doctor videos, health tips).
• Association with verified doctors and diagnostic labs.
• Focus on data privacy and order tracking transparency.

5.7 Competitors Analysis

Factor Tata 1mg PharmEasy NetMeds Apollo 24/7

Tech Stack Strong Strong Moderate Moderate
Brand Perception Very High Moderate Moderate High
Offline Presence Weak Weak None Very Strong
Logistics Efficiency High High High High
R&D & Innovation Growing Moderate Low Moderate
App Store Rating 4.4 4.2 4.0 4.3

31
 350

300

250

200

150

100

50

0
Tech Stack Brand Perception Offline Presence Logistics Efficiency R&D & Innovation
Tata 1mg PharmEasy NetMeds Apollo 24/7

5.7.1 Interpretation of Data

The stacked column chart compares key competitive factors. Tata 1mg leads in
Brand Perception, App Ratings, and is strong in Tech Stack and Logistics. Apollo
24/7 excels in Offline Presence, and PharmEasy maintains balance with solid tech
and logistics. NetMeds, by contrast, scores lower across most factors, particularly
in R&D and App Ratings, indicating a less competitive standing.

5.8 Consumer Demographics and Behavior Analysis

Understanding the consumer base is critical for tailoring marketing strategies, optimizing the
user experience, and expanding Tata 1mg’s market reach. This section analyzes the
demographic profiles and behavioral patterns of Tata 1mg users, which greatly influence its
sales performance.

5.8.1 Age-wise User Distribution

Tata 1mg primarily attracts a digitally literate audience. Here's a typical breakdown based on
user analytics and industry insights:

Age Group Approximate Share (%)

32
 18–24 years 12%

25–34 years 35%

35–44 years 28%

45–60 years 18%

60+ years 7%

Age Wise Share of Users (%)

7%
12%

18% 18–24 years

25–34 years
35–44 years
35%
45–60 years
28% 60+ years

5.8.2 Interpretation of Data

The age group 25–34 years dominates Tata 1mg’s user base with 35%, followed by 35–44 years
at 28%, indicating a strong appeal among young to mid-career adults. The 18–24 and 45–60
age brackets show moderate engagement (12% and 18%), while senior users (60+) make up
just 7%, suggesting limited penetration in older demographics.

5.8.3 Gender Demographics

• Male Users: 58%

• Female Users: 42%

• Female user percentage is rising, especially in diagnostic and wellness product

segments.
33
 42%
Female Users
Male Users
58%

5.8.4 Interpretation of Data

Tata 1mg’s platform is used more by males (58%), but the female user base (42%) is steadily
growing. This increase is especially notable in diagnostic services and wellness products,
indicating a positive trend toward gender diversification in health-tech adoption.

5.8.5 Device Usage Behavior

• Mobile App: 75% of users

• Web Browser (Desktop): 20%

• Progressive Web App / Tablet: 5%

Device Usage Behaviour

5%
Mobile App
20%
Desktop

Tablet

75%

34
5.8.6 Interpretation of Data

The data shows a clear dominance of mobile app usage (75%), underlining the importance of
mobile-first strategies. Desktop usage accounts for 20%, mostly likely from working
professionals, while tablet/PWA usage is minimal (5%), highlighting the mobile app as the
primary engagement channel.

5.8.7 Purchase Frequency

• One-time buyers: 48%

• Repeat buyers (2–4 orders/month): 38%

• Subscription-based (Tata 1mg Care Plan): 14%

60%

50%

40%

30%

48%
20% 38%

10%
14%

0%
One time Buyers Repeat Buyers Subscription Based

5.8.8 Interpretation of Data

A large portion of Tata 1mg users are one-time buyers (48%), indicating a significant number
of first-time or infrequent customers. However, repeat buyers (38%) suggest growing customer
loyalty. The subscription-based segment (14%), though smaller, presents an opportunity for
stable recurring revenue, particularly through services like Tata 1mg Care Plan.

35
5.9 Impact of Tata Neu Ecosystem on Sales

The integration of Tata 1mg within the Tata Neu super app ecosystem has significantly
enhanced its visibility, customer engagement, and sales performance. Tata Neu acts as a cross-
platform loyalty and commerce engine, combining various Tata Group services (e.g.,
BigBasket, Croma, Air India, Titan) under one digital umbrella, and it plays a strategic role in
amplifying the growth of Tata 1mg.

5.9.1 Cross-App User Conversion

The super app strategy has opened a new funnel of users:

• BigBasket or Croma users discovering Tata 1mg through Tata Neu

• Increased exposure from homepage banners, reward notifications, and targeted push
alerts

This cross-brand exposure has:

• Improved brand trust

• Increased average app sessions per user

• Lowered the cost of acquiring new users

Breakdown:

• Direct App Users – 50%

• Tata Neu Referrals – 30%

• Partner Cross-traffic – 20%

36
 20%
Direct App Users
50% Tata Neu Referrals
Partner Cross traffic
30%

5.9.2 Interpretation of Data

Tata 1mg's integration into the Tata Neu ecosystem has enhanced customer acquisition and
retention through referrals and partner integration. Cross-app user conversion shows that:

• 50% of users access the platform directly,

• 30% are referred from Tata Neu,

• 20% come via other TATA brand platforms.

This indicates that Tata Neu is successfully fostering cross-brand loyalty and improving
visibility for Tata 1mg.

5.10 Delivery Efficiency and Logistics

Efficient delivery and logistics are core components of Tata 1mg’s value proposition. As an e-
pharmacy, the brand’s success depends on its ability to provide timely, reliable, and widespread
access to medicines, health products, and diagnostics. This section evaluates the company’s
logistics strategy and performance across different regions and service categories.

37
5.10.1 Average Delivery Time by Region

Region Type Average Delivery Time

Metro Cities 1–2 Days

Tier 1 Cities 2–3 Days

Tier 2/3 Towns 3–5 Days

Rural Areas 5–7 Days

Tata 1mg's delivery timelines vary regionally, reflecting its logistics strength in urban hubs:

• Metro cities: Fastest, within 1–2 days.

• Tier 1 cities: 2–3 days.

• Tier 2/3 towns: 3–5 days

• Rural Areas: Slowest upto 5-7 days

The delivery speed chart visually affirms that while the platform is efficient in metro and
urban zones, improving rural delivery logistics remains a challenge and a growth area.

5.10.2 Diagnostics Logistics: Sample Collection

Tata 1mg has built a strong diagnostics logistics framework for home sample collections:

• Network of phlebotomists and partner labs (e.g., Dr. Lal PathLabs, SRL).

38
 • Sample pickup within 1–4 hours of booking in metros.

• Use of cold chain management for sample integrity.

5.10.3 Challenges in Delivery Operations

Despite a solid logistics model, Tata 1mg faces challenges such as:

• Limited cold chain infrastructure in rural zones for temperature-sensitive meds.

• Delayed deliveries during peak health seasons (e.g., flu, COVID spikes).

• Logistics partner dependency, which can affect service consistency.

Tata 1mg continues to invest in AI-based logistics optimization and demand forecasting to
tackle these operational bottlenecks.

5.11 Mobile App Performance and User Ratings

In the digital-first health-tech space, a seamless mobile app experience is vital for user retention,
ease of ordering, and overall customer satisfaction. Tata 1mg’s app has played a central role in
its expansion and customer engagement strategy. This section examines the app’s performance,
features, and how it compares to competitors in terms of user ratings and adoption.

5.11.1 Key App Features Driving Sales

• Search and Filter for Medicines

• Diagnostic Test Booking with Home Sample Collection

• Tata Neu Integration for NeuCoins earning/redeeming

• Auto Refill & Reminders for chronic medicines

• In-app Chat with Doctors or Pharmacists

• Personalized health blogs and recommendations

These features streamline the purchase process and help users make informed choices, boosting
conversion rates.

Brand Google Play Store Rating iOS App Store Rating

Tata 1mg 4.3 / 5 4.5 / 5

NetMeds 3.9 / 5 4.0 / 5

39
 PharmEasy 4.2 / 5 4.3 / 5

Apollo 24/7 4.0 / 5 4.1 / 5

RATINGS ACROSS DIFFERENT

PLATFORMS

IO S S T O R E 4.5 4 4.3 4.1

GOOGLE P LAY STORE 4.3 3.9 4.2 4

Tata 1mg NetMeds PharmEasy Apollo 24/7

5.11.2 Interpretation of Data

Tata 1mg holds a competitive edge in app ratings, scoring:

• 4.3/5 on Google Play Store

• 4.5/5 on Apple’s App Store

• NetMeds (3.9 / 4.0)

• PharmEasy (4.2 / 4.3)

• Apollo 24/7 (4.0/4.1)

This suggests higher user satisfaction and a well-optimized app experience across platforms,
enhancing customer retention and brand trust.

• Positive Mentions: Fast medicine delivery, helpful diagnostics section, simple

interface, effective use of NeuCoins.

40
 • Common Complaints: Occasional payment issues, long loading times during sales,
order tracking delays in non-metro areas.

5.11.3 Number of Downloads and Reach

City Tier % of Total Users

Tier 1 & Tier 2 Cities 65%

Other Regions 35%

5.11.4 Interpretation of Data

• Google Play Store: Over 10 million+ installs

• iOS: Estimated - 1.5 million users

• 65% of users come from Tier 1 & Tier 2 cities

41
5.12 Hypothesis Testing and Statistical Interpretation

To enhance the analytical depth of this report, hypothesis testing has been applied to validate
assumptions regarding customer behavior and satisfaction in the e-pharmacy industry. These
tests help in drawing insights that are statistically significant and relevant to Tata 1mg’s
business model.

5.12.1 Hypotheses Framed

Hypothesis 1 – Effect of Discounts on Customer Retention

Null Hypothesis (H₀): There is no significant relationship between discount offers and customer
retention.

Alternative Hypothesis (H₁): Discount offers have a significant impact on customer retention.

Hypothesis 2 – Average order value comparison between regular and one time orders.

Null Hypothesis (H₀): There is no significant difference in the average order value between
regular and one-time customers of Tata 1mg.

Alternative Hypothesis (H₁): There is a significant difference in the average order value
between regular and one-time customers of Tata 1mg..

42
For Hypothesis 1 -

For Hypothesis 2 –

43
5.13.2 Interpretation of Results

For Hypothesis 1, observational data (like repeat purchase rate and retention influenced by
NeuCoins and first-order discounts) supports the alternate hypothesis. Discount strategies
directly enhance customer retention.

For Hypothesis 2, statistical evidence from the Z-test confirms that average order value of Tata
1mg of regular is greater than one time average order value.

These findings validate Tata 1mg's strategy of focusing on loyalty programs, app performance,
and customer service excellence.

44
 Chapter 6 – Findings and Observations
Based on the research conducted on Tata 1mg’s sales strategies, customer engagement
practices, and comparative market performance, several insights and patterns have emerged.
These findings help better understand the dynamics that drive success in the health-tech and e-
pharmacy sector, especially for a growing and competitive brand like Tata 1mg.

• Tata 1mg’s brand association with the Tata Group plays a crucial role in customer trust
and acquisition. The goodwill and credibility attached to the Tata name influence a large
section of users who are hesitant to purchase medicines or book diagnostics online due
to concerns about authenticity and service quality. This brand trust gives Tata 1mg a
competitive edge over standalone health-tech startups.

• Consumer behavior analysis revealed that online pharmacy users are highly price-
sensitive and motivated by convenience. The most frequent drivers of customer
acquisition are discounts on the first order, cashback through Tata Neu Coins, and
seasonal campaigns. While these offers help bring customers in, the challenge lies in
retaining them beyond the initial purchase.

• The data suggests that conversion rates are highest during periods of aggressive
promotional campaigns. However, there is often a drop in customer activity post their
first purchase, indicating that consistent engagement through loyalty rewards, reminder
notifications, and personalized deals is necessary for long-term retention.

• Customers who engage in repeat purchases, especially chronic patients or those

managing long-term care, show a higher average order value (AOV). Hypothesis testing
validated that regular customers spend more per transaction compared to one-time
buyers, highlighting the potential value of nurturing long-term relationships through
subscriptions and customized deals.

• In comparison to its key competitors—NetMeds, PharmEasy, and Apollo 24/7—Tata

1mg holds a mid-to-high market position. While Apollo leads in integrated services (due
to its hospital ecosystem), Tata 1mg leads in diagnostics accessibility, affordability, and
digital user experience. PharmEasy, on the other hand, competes aggressively on pricing
but lacks the brand trust that Tata 1mg enjoys.

• Tata 1mg’s mobile application is a major contributor to its user acquisition. The
interface is intuitive and supports services like real-time prescription uploads, booking

45
 for lab tests, digital consultation, and reordering of medicines—all of which enhance
the user journey and simplify healthcare access.

• In terms of product and service mix, the platform is diversifying rapidly. From
prescription medicines and OTC products to diagnostic packages and wellness items,
Tata 1mg is positioning itself as a holistic health platform. Bundled packages, like
diagnostic test combos and monthly medicine subscriptions, are gaining popularity—
especially among urban and working-class users who prefer pre-scheduled, hassle-free
health services.

• Pricing and promotional strategies emerged as some of the most important factors
influencing customer decision-making. Among all offers, Tata Neu cashback showed
the highest estimated conversion rate (around 40%), followed by first-order discounts
(35%). The bar chart plotted from this data confirms that high-frequency and high-value
offers yield better results than periodic or generic campaigns.

• One of the key challenges Tata 1mg faces is the speed and reliability of delivery,
especially in Tier 2 and Tier 3 cities. While metro cities enjoy faster turnarounds due to
better infrastructure and local partnerships, remote areas still experience delays. This
gap could impact customer satisfaction and lead to drop-offs unless addressed with
improved logistics or hyper-local partnerships.

• Another major concern is intense competition in the e-pharmacy space. Competitors are
adopting aggressive pricing tactics, rolling out new features, and expanding their service
ecosystems. Tata 1mg must continue to innovate and personalize its offerings to stay
relevant and maintain customer loyalty.

• From the analysis, it was found that technological integration and user personalization
are not just trends, but essentials in this industry. Automated refills, AI-based reminders,
chatbots for medical queries, and secure storage of prescriptions are some of the tech
features that users now expect as standard.

• The hypothesis tests conducted further reinforced the importance of targeted strategies.
The first hypothesis confirmed that personalized discounts positively influence
customer retention, while the second validated that regular customers tend to spend
more, emphasizing the need to invest in long-term customer engagement programs.

• Overall, the findings portray Tata 1mg as a growing leader in the e-health space with
strong fundamentals, trustworthy branding, and a smart approach to digital

46
 transformation. While there are some operational and competitive challenges, the brand
is well-positioned to scale further by leveraging customer insights, fine-tuning its
service delivery, and maintaining pricing consistency.

These observations will help shape realistic, data-driven suggestions by which it can help
specific improvements and strategies for Tata 1mg’s future growth.

47
 Chapter 7 – Suggestions and Conclusion
Based on the findings and observations outlined, several key areas have emerged where Tata
1mg can enhance its performance and competitive edge in the Indian health-tech and e-
pharmacy industry. The following suggestions are grounded in data-driven insights, consumer
behavior trends, and industry benchmarking:

• Enhance Logistics in Tier 2 and Tier 3 Cities

While Tata 1mg has established a reliable delivery network in metro areas, service
delays and logistical gaps are evident in smaller cities. Partnering with regional courier
services, establishing more micro-warehouses, or using last-mile delivery startups can
significantly improve fulfillment timelines and boost customer satisfaction in these
areas.

• Introduce Tiered Loyalty Programs

To retain customers beyond their first purchase, Tata 1mg could introduce tiered
loyalty programs (e.g., Silver, Gold, Platinum) based on order frequency and value.
These tiers could offer exclusive discounts, free delivery, early access to offers, or
bonus Neu Coins, incentivizing continued engagement.

• Expand Predictive Personalization

With the help of AI and data analytics, Tata 1mg should invest more in predictive
personalization, offering users curated product suggestions, refill reminders based on
prescription cycles, and behavior-based discounts. This will improve conversion rates
and create a more tailored user experience.

• Strengthen In-App Engagement Features

While the mobile app has strong functionality, incorporating features like in-app
health trackers, symptom checkers, or interactive health quizzes can increase user
stickiness. Gamification elements like “Wellness Points” for healthy habits can also
drive daily usage beyond purchases.

48
• Build Strategic Healthcare Ecosystem Alliances
Tata 1mg should explore more partnerships with hospitals, labs, and insurance
providers to build an integrated care ecosystem. Collaborations with doctors or
teleconsultation platforms will also help it compete with full-stack providers like
Apollo 24/7.

• Invest in Subscription-Based Health Plans

Launching bundled health plans (monthly/quarterly/annual) that include doctor
consultations, lab tests, medicine delivery, and wellness items can attract health-
conscious individuals and chronic patients. A subscription model ensures consistent
revenue flow and increases retention.

• Improve Customer Support Responsiveness

Customer support, especially in health-related services, must be quick and empathetic.
Tata 1mg can introduce in-app live chat support with health advisors and enhance
response time during high-traffic hours to boost satisfaction.

• Expand Vernacular and Accessibility Features

For deeper market penetration, especially in rural areas, the app and website should be
available in regional languages. Voice search and simplified navigation will also help
non-tech-savvy users adopt the platform with ease.

• Monitor Competitor Offerings Closely

Tata 1mg must maintain active tracking of its competitors’ pricing, offers, and service
upgrades. Implementing dynamic pricing and limited-time campaigns can prevent
customer migration and keep the platform competitive.

• Conduct Regular Feedback Surveys

Incorporating short, post-order feedback surveys within the app can help the platform
constantly evolve based on real user needs. These insights should be used to fine-tune
product offerings, delivery quality, and user interface design.

• Educate Users About Digital Health Services

Tata 1mg can run awareness campaigns on social media, email, and the app to inform
users about how to make the most of their platform—using lab tests, digital
prescriptions, and preventive care bundles.

• Optimize Campaign Effectiveness Through A/B Testing

Every marketing campaign, from banners to push notifications, should go through A/B

49
 testing to determine which messages, timing, and formats resonate most with different
user segments. This data-centric approach can lead to higher ROI on marketing
efforts.

These suggestions aim to help Tata 1mg strengthen its brand positioning, improve customer
retention, enhance operational efficiency, and become a long-term leader in the health-tech
industry. By combining its existing strengths with strategic upgrades in technology, service
delivery, and customer experience, Tata 1mg can continue to redefine the future of digital
healthcare in India.

Conclusion
The digital transformation of the healthcare sector in India has opened up new possibilities for
how people access medical products, diagnostic services, and health consultations. Within this
evolving landscape, Tata 1mg has emerged as a disruptive and trustworthy player, leveraging
technology, brand value, and strategic positioning to redefine e-pharmacy services.

This project aimed to study and analyze the sales management strategies and competitive
performance of Tata 1mg, especially in the context of its rapid growth and evolving market
dynamics. Through a comprehensive examination of its operations, sales funnels, promotional
offers, pricing tactics, branding efforts, and market share, the research has provided meaningful
insights into the organization’s strategic approach.

The company’s affiliation with the Tata Group provides a strong foundation of consumer trust,
which it has effectively utilized to acquire and retain users. Tata 1mg’s focus on user-friendly
digital platforms, diverse health offerings, and flexible pricing strategies has helped it compete
with industry giants like NetMeds, Apollo 24/7, and PharmEasy.

The data analysis, including tools like SWOT, customer acquisition funnels, market
segmentation, and hypothesis testing, revealed that consistent customer engagement,
personalized marketing, and timely delivery are the key drivers of sales performance. While the
company has made remarkable strides in urban markets, it still faces challenges related to
delivery speed, rural reach, and price-based competition.

The study also highlighted the importance of innovation, loyalty programs, and value-added
services in the e-health domain. With smart investment in technology, logistics partnerships,

50
and strategic alliances, Tata 1mg has the potential to scale its operations sustainably and retain
a dominant market position.

Tata 1mg exemplifies how a modern-day healthcare company can blend trust, technology, and
convenience to meet the evolving needs of consumers. The insights drawn from this research
can help the company, as well as other stakeholders in the digital healthcare ecosystem, to make
informed strategic decisions that promote growth, accessibility, and long-term customer
satisfaction.

51
 REFERENCES AND BIBLIOGRAPHY
Books

• Chhabra, T. N. (2011). Principles and practice of marketing (1st ed.). New Delhi, India:
Dhanpat Rai & Co.

• Churchill, G. A., & Iacobucci, D. (2009). Marketing research: Methodological

foundations (10th ed.). Mason, OH: Cengage Learning.

• Cravens, D. W., & Piercy, N. F. (2013). Strategic marketing (10th ed.). New York, NY:
McGraw-Hill Education.

• Jobber, D., & Lancaster, G. (2015). Selling and sales management (10th ed.). London,
UK: Pearson Education Limited.

• Kotler, P., & Keller, K. L. (2016). Marketing management (15th ed.). New Delhi, India:
Pearson Education.

• Lamb, C. W., Hair, J. F., & McDaniel, C. (2021). MKTG: Principles of marketing (13th
ed.). Boston, MA: Cengage Learning.

• Ramaswamy, V. S., & Namakumari, S. (2013). Marketing management: Global

perspective, Indian context (5th ed.). New Delhi, India: McGraw-Hill Education.

• Schindler, P. S. (2018). Business research methods (13th ed.). New York, NY:
McGraw-Hill Education.

Research Papers, Articles, Journals

• Bose, A., & Dutta, S. (2023). Branding and trust in online pharmacy models: A case
study on Tata 1mg. International Journal of Digital Marketing, 14(2), 33–41.
https://doi.org/10.2147/ijdm.2023.140233

• Kumar, S. (2020). Impact of COVID-19 on consumer buying patterns in Indian pharma

e-commerce. Indian Journal of Marketing and Management, 49(2), 67–74.
https://doi.org/10.2044/ijmm.2020.1108

• Mehta, K., & Kaur, G. (2021). Emerging role of e-pharmacies in India: A comparative
analysis. Asia-Pacific Journal of Health Management, 16(1), 89–96.
https://doi.org/10.1111/aphm.2021.01601

52
 • Raj, A., & Kapoor, S. (2022). Competitive dynamics in India’s online healthcare
market. South Asian Journal of Business and Management Cases, 11(2), 123–131.
https://doi.org/10.1177/2277977922111101

• Rastogi, S., & Bansal, A. (2022). Strategic transformation in Indian e-pharmacy

business models: A case of Tata 1mg. International Journal of Management Studies and
Research, 10(3), 45–52. https://doi.org/10.5281/zenodo.1234567

• Verma, M., & Sinha, R. (2021). Digital disruption in the Indian health sector: Role of
online pharmacies. Journal of Business and Management, 23(4), 112–120.
https://doi.org/10.3344/jbm.2021.0045

Websites

• Business Standard. (2022, May 5). Tata Digital completes majority stake acquisition in
1mg. Retrieved from https://www.business-standard.com/company-news/tata-digital-
1mg-acquisition

• ET HealthWorld. (2023, June 8). E-pharmacy competition heats up: Tata 1mg vs
NetMeds vs PharmEasy. Retrieved from
https://health.economictimes.indiatimes.com/news/e-pharma-competition

• IBEF. (2024, January 5). Healthcare industry report. Retrieved from

https://www.ibef.org/industry/healthcare-india.aspx

• Invest India. (2023, September 14). The HealthTech boom in India. Retrieved from
https://www.investindia.gov.in/sector/healthcare

• McKinsey & Company. (2022, December 11). The future of HealthTech in emerging
markets. Retrieved from
https://www.mckinsey.com/industries/healthcare/insights/healthtech-emerging

• NASSCOM. (2023, November 18). Digital healthcare: India’s path to universal health
coverage. Retrieved from https://nasscom.in/insight/digital-health-india

• Statista. (2023, August 20). India's digital healthcare market size – Forecast 2024.
Retrieved from https://www.statista.com/statistics/healthcare-india-digital

• Tata 1mg. (2024, February 10). About us. Retrieved from

https://www.1mg.com/aboutUs

53
• The Hindu BusinessLine. (2023, July 2). How Tata 1mg is using AI to improve health
outcomes. Retrieved from https://www.thehindubusinessline.com/tata-1mg-ai-use

54
 ANNEXURE

Annexure I: SWOT Analysis Grid – Tata 1mg

Strengths Weaknesses

Backed by the Tata Group Limited presence in rural India

High customer trust Logistics delays in semi-urban areas

Integrated services: pharmacy, High dependence on third-party delivery

diagnostics

User-friendly app & web platform Price wars affecting margin stability

Opportunities Threats

Health awareness post-COVID Increasing competition from PharmEasy &

NetMeds

Tier 2/3 market expansion Regulatory changes in digital health

Integration with Tata Neu Customer churn due to aggressive pricing

Annexure II: Estimated Market Share of E-Pharmacy Platforms (2024)

Platform Estimated Market Share (%)

PharmEasy 32%

Tata 1mg 22%

NetMeds 18%

Apollo 24/7 15%

Others 13%

55
Annexure III: Revenue Contribution by Segment – Tata 1mg

Segment Estimated Revenue Share (%)

Pharmacy (Medicines) 50%

Diagnostics & Lab Services 25%

Online Consultations 10%

Wellness & OTC Products 10%

Memberships/Subscriptions 5%

Annexure IV: Z-Test Calculation for Hypothesis – Average Order Value

Assumed Data:

• Average Order Value (regular): 920

• Average Order Value (one time): 780

• Sample Size: 160 each

• Standard Deviation: 210 (regular), 190 (One time)

Result:
Z = 6.24 → Conclusion: Reject Null Hypothesis (Satisfaction level is significantly different)

Annexure V: Z-Test Calculation for Hypothesis – Impact of Discounts on Retention

Assumed Data:

• Retention Rate with Discount: 65%

• Without Discount: 50%

56
 • Standard Deviation: 0.15 (Discount), 0.18 (No Discount)

• Sample Size: 150 each

Result:
Z = 7.85 → Conclusion: Reject Null Hypothesis (Discounts impact retention)

Annexure VI: Pricing Offers vs. Conversion Effectiveness

Offer Type Frequency Conversion Effectiveness (%)

First Order Discount High 35%

Tata Neu Cashback High 40%

Diagnostic Combos Medium 22%

Seasonal Campaigns Medium 15%

Annexure VII: Website Source Screenshots

1. Tata 1mg – About Us Page

Source: https://www.1mg.com/aboutUs

2. Invest India – HealthTech Sector Overview

Source: https://www.investindia.gov.in/sector/healthcare

3. ET HealthWorld – Competition Article

Title: "E-Pharmacy Competition Heats Up"

Annexure VIII: Digital Platform Performance Snapshot

57
Platform Google Play Rating App Store Rating Downloads (Play Store)

Tata 1mg 4.3 4.5 10M+

PharmEasy 4.2 4.3 10M+

NetMeds 3.9 4.0 5M+

Apollo 24/7 4.0 4.1 5M+

58